Solvay SA (SOLB) | Financial Analysis & Statements
Solvay SA Large-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.1B
Gross Profit
235.0M
21.46%
Operating Income
61.0M
5.57%
Net Income
-93.0M
-8.49%
EPS (Diluted)
€-0.90
Balance Sheet Metrics
Total Assets
6.2B
Total Liabilities
5.1B
Shareholders Equity
1.1B
Debt to Equity
4.69
Cash Flow Metrics
Operating Cash Flow
109.0M
Free Cash Flow
204.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Solvay SA Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.7B | 5.1B | 6.0B | 8.0B | 11.4B |
| Cost of Goods Sold | 3.7B | 4.0B | 4.6B | 6.6B | 8.5B |
| Gross Profit | 1.0B | 1.1B | 1.4B | 1.4B | 2.9B |
| Gross Margin % | 21.1% | 22.3% | 23.0% | 17.8% | 25.6% |
| Operating Expenses | |||||
| Research & Development | 23.0M | 34.0M | 47.0M | 46.0M | 325.0M |
| Selling, General & Administrative | 489.0M | 419.0M | 526.0M | 565.0M | 1.2B |
| Other Operating Expenses | 11.0M | 38.0M | - | -171.0M | -50.0M |
| Total Operating Expenses | 523.0M | 491.0M | 573.0M | 440.0M | 1.5B |
| Operating Income | 476.0M | 651.0M | 803.0M | 805.0M | 1.2B |
| Operating Margin % | 10.0% | 12.7% | 13.3% | 10.1% | 10.7% |
| Non-Operating Items | |||||
| Interest Income | 10.0M | 17.0M | 36.0M | 38.0M | 10.0M |
| Interest Expense | 125.0M | 123.0M | 133.0M | 54.0M | 107.0M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 157.0M | 320.0M | 180.0M | 1.1B | 1.1B |
| Income Tax | 120.0M | 87.0M | 208.0M | 228.0M | 110.0M |
| Effective Tax Rate % | 76.4% | 27.2% | 115.6% | 20.1% | 10.1% |
| Net Income | 37.0M | 233.0M | 2.1B | 1.9B | 989.0M |
| Net Margin % | 0.8% | 4.5% | 34.9% | 24.2% | 8.6% |
| Key Metrics | |||||
| EBITDA | 942.0M | 1.1B | 1.9B | 2.0B | 2.3B |
| EPS (Basic) | €0.28 | €2.12 | €20.09 | €18.37 | €9.15 |
| EPS (Diluted) | €0.28 | €2.10 | €19.85 | €18.30 | €9.13 |
| Basic Shares Outstanding | 104471924 | 105000897 | 104160774 | 103744461 | 103527423 |
| Diluted Shares Outstanding | 104471924 | 105000897 | 104160774 | 103744461 | 103527423 |
Income Statement Trend
Solvay SA Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 536.0M | 539.0M | 584.0M | 932.0M | 941.0M |
| Short-term Investments | 19.0M | 17.0M | 127.0M | 758.0M | 1.3B |
| Accounts Receivable | 622.0M | 826.0M | 840.0M | 2.0B | 1.8B |
| Inventory | 587.0M | 623.0M | 642.0M | 2.1B | 1.7B |
| Other Current Assets | -2.0M | - | 3.0M | 1.0M | -1.0M |
| Total Current Assets | 2.2B | 2.5B | 2.7B | 7.0B | 6.8B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 487.0M | 407.0M | 2.3B | 11.5B | 680.0M |
| Goodwill | 1.7B | 1.8B | 1.7B | 9.0B | 8.9B |
| Intangible Assets | 202.0M | 218.0M | 201.0M | 2.0B | 2.1B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 225.0M | 218.0M | 267.0M | 470.0M | 723.0M |
| Total Non-Current Assets | 4.0B | 4.2B | 4.3B | 13.7B | 13.2B |
| Total Assets | 6.2B | 6.7B | 7.0B | 20.7B | 20.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 773.0M | 810.0M | 850.0M | 2.3B | 2.1B |
| Short-term Debt | 331.0M | 153.0M | 151.0M | 508.0M | 770.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 74.0M | 460.0M | 586.0M | 1.5B | 95.0M |
| Total Current Liabilities | 1.8B | 1.9B | 2.2B | 4.9B | 5.5B |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.8B | 1.7B | 243.0M | 2.4B | 2.5B |
| Deferred Tax Liabilities | 120.0M | 136.0M | 131.0M | 558.0M | 462.0M |
| Other Non-Current Liabilities | 61.0M | 53.0M | 70.0M | 304.0M | 332.0M |
| Total Non-Current Liabilities | 3.2B | 3.4B | 3.5B | 5.1B | 5.7B |
| Total Liabilities | 5.1B | 5.3B | 5.7B | 10.0B | 11.2B |
| Equity | |||||
| Common Stock | 237.0M | 237.0M | 237.0M | 1.6B | 1.6B |
| Retained Earnings | 1.5B | 1.7B | 1.7B | 6.9B | 5.5B |
| Treasury Stock | 44.0M | 44.0M | 15.0M | 225.0M | 232.0M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.1B | 1.4B | 1.3B | 10.7B | 8.9B |
| Key Metrics | |||||
| Total Debt | 2.1B | 1.9B | 394.0M | 2.9B | 3.3B |
| Working Capital | 311.0M | 563.0M | 522.0M | 2.1B | 1.3B |
Balance Sheet Composition
Solvay SA Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 37.0M | 233.0M | 2.1B | 1.9B | 989.0M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 257.0M | -16.0M | 416.0M | -690.0M | -866.0M |
| Operating Cash Flow | 386.0M | 280.0M | 1.2B | 1.4B | 104.0M |
| Investing Activities | |||||
| Capital Expenditures | -173.0M | -261.0M | -960.0M | -794.0M | -531.0M |
| Acquisitions | 5.0M | -12.0M | -732.0M | 80.0M | 125.0M |
| Investment Purchases | - | -13.0M | - | -14.0M | -22.0M |
| Investment Sales | - | - | 0 | 0 | 2.0M |
| Investing Cash Flow | -168.0M | -286.0M | -1.7B | -730.0M | -426.0M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -261.0M | -260.0M | -424.0M | -417.0M | -431.0M |
| Debt Issuance | 342.0M | 1.7B | 3.2B | 248.0M | 248.0M |
| Debt Repayment | -384.0M | -1.7B | -2.8B | -796.0M | -614.0M |
| Financing Cash Flow | -307.0M | -228.0M | -344.0M | -1.0B | -952.0M |
| Free Cash Flow | 462.0M | 330.0M | 847.0M | 1.1B | 863.0M |
| Net Change in Cash | -89.0M | -234.0M | -818.0M | -397.0M | -1.3B |
Cash Flow Trend
Solvay SA Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
99.64
Forward P/E
9.79
Price to Book
2.86
Price to Sales
0.61
PEG Ratio
-0.24
Profitability Ratios
Profit Margin
0.63%
Operating Margin
2.29%
Return on Equity
2.98%
Return on Assets
4.23%
Financial Health
Current Ratio
1.17
Debt to Equity
200.56
Beta
0.24
Per Share Data
EPS (TTM)
€0.28
Book Value per Share
€9.76
Revenue per Share
€45.43
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| SOLB | 2.9B | 99.64 | 2.86 | 2.98% | 0.63% | 200.56 |
| Syneos Health | 5.7B | 377.86 | 0.94 | -1.25% | -1.04% | 48.61 |
| Titan Cement | 3.5B | 14.74 | 1.77 | 13.18% | 8.85% | 33.45 |
| Azelis Group NV | 2.5B | 22.61 | 0.94 | 4.03% | 2.71% | 69.00 |
| Tessenderlo Group NV | 1.3B | 37.21 | 0.74 | -4.43% | -2.94% | 11.70 |
Financial data is updated regularly. All figures are in the company's reporting currency.